Literature DB >> 4184022

Effect of heptabarbital on the response to bishydroxycoumarin in man.

P M Aggeler, R A O'Reilly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4184022

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  10 in total

1.  Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man.

Authors:  D D Breimer; A G de Boer
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

Review 2.  Interindividual differences in the response to oral anticoagulants.

Authors:  A M Breckenridge
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

Review 3.  [Drugs interacting with coumarine oral anticoagulants (author's transl)].

Authors:  R Gugler; H J Dengler
Journal:  Klin Wochenschr       Date:  1973-11-15

4.  [Changes in the velocity of drug catabolism and their importance in drug therapy].

Authors:  G F Kahl
Journal:  Klin Wochenschr       Date:  1971-04-01

Review 5.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  Genetic control of phenylbutazone metabolism in man.

Authors:  J A Whittaker; D A Evans
Journal:  Br Med J       Date:  1970-11-07

7.  The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.

Authors:  E E Ohnhaus; W Berger; F Duckert; F Oesch
Journal:  Klin Wochenschr       Date:  1983-09-01

Review 8.  Clinical pharmacokinetics of oral anticoagulants.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

9.  Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.

Authors:  R A O'Reilly; W F Trager; C H Motley; W Howald
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

10.  Induction of drug metabolism in the rat by taglutimide, a sedative-hypnotic glutarimide derivative.

Authors:  H Wiener; P Krivanek; E Tuisl; N Kolassa
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.